Christy E. Trussoni

Christy E. Trussoni

Auto-generated profile, based on publicly available information

Christy E. Trussoni

Center for Cell Signaling in Gastroenterology, Mayo Clinic, Rochester, Minnesota

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2025 in Clinical Cancer Research
Verified
Journal Article
Closed access
BSBahar Saberzadeh-Ardestani
Bahar Saberzadeh-Ardestani
ZLZhenglong Liu
Zhenglong Liu
MSMariam I. Stein
Mariam I. Stein
WSWill A. Sherman
Will A. Sherman
CTChristy E. Trussoni
Christy E. Trussoni
FSFrank Sinicrope
Frank Sinicrope
Purpose: Digital proteomic profiling was performed to identify spatial context in relationship to patient response and survival after anti–PD-1 therapy in metastatic colorectal cancer. Experimental Design: Primary colorectal cancers with deficient mismatch repair from patients treated with anti–PD-1 antibodies were analyzed (N = 30) using digital spatial profiling (GeoMx nCounter). At the invasive margin, 71 proteins were profiled in 10 regions of interest/slide that were segmented into 3 compartments labeled with pan-cytokeratin (epithelia), CD45 (stromal cells), and SYTO13 (nuclei). In an independent cohort (n = 13), digital spatial profiling data and single-cell transcriptomic data were analyzed. Differential protein abundance, after Benjamini–Hochberg correction, was examined by clinical response and progression-free survival (PFS) using multivariable Cox regression. Results: Protein abundance varied significantly between epithelial and stromal compartments. Nonresponders to anti–PD-1 showed higher fibronectin and smooth muscle actin abundance in the epithelial compartment that was associated with significantly shorter PFS (adjusted HR: 6.49 and 4.52, respectively; P < 0.05). In CD45+ stroma, increased expression of proteins related to T cells (CD3 and CD4), NK cells (CD56), antigen presentation (CD40), immune activation (CD27, ICOS), and apoptosis (GZMA) were found in responders (vs nonresponders) to anti–PD-1; each marker was significantly associated with longer patient PFS (0.02 < adjusted HR < 0.17; P < 0.05). In a separate cohort, consistent results by compartment were found for fibronectin and CD56. Gene expression data revealed that fibronectin and smooth muscle actin were primarily derived from cancer-associated fibroblasts. Conclusions: Spatially resolved protein profiles within microenvironments of deficient mismatch repair colorectal cancers can influence patient response and survival after anti–PD-1, highlighting their potential clinical significance.

10 October 2023 in Journal of Hepatology
Verified
Journal Article
Closed access
CTChristy E. Trussoni
Christy E. Trussoni
NLNicholas F. LaRusso
Nicholas F. LaRusso

31 March 2022 in Seminars in Immunopathology
Verified
Journal Article
Open access
PDF file
CTChristy E. Trussoni
Christy E. Trussoni
SOSteven O'Hara
Steven O'Hara
NLNicholas F. LaRusso
Nicholas F. LaRusso

1 May 2025
Verified
Other
Open access
BSBahar Saberzadeh-Ardestani
Bahar Saberzadeh-Ardestani
ZLZhenglong Liu
Zhenglong Liu
MSMariam I. Stein
Mariam I. Stein
WSWill A. Sherman
Will A. Sherman
CTChristy E. Trussoni
Christy E. Trussoni
FSFrank Sinicrope
Frank Sinicrope
Figure 3 from Spatially Resolved, Multiregion Proteomics for Prediction of Immunotherapy Outcome in Deficient Mismatch Repair Metastatic Colorectal Cancer